Osaic Holdings
SKYE icon

Osaic Holdings’s Skye Bioscience SKYE Stock Holding History

Osaic Holdings’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$364 Buy
600
+598
+29,900% +$487 ﹤0.01% 7489
2025
Q4 		$1 Sell
2
-16
-89% -$23 ﹤0.01% 7817
2025
Q3 		$63 Sell
18
-159
-90% -$600 ﹤0.01% 7776
2025
Q2 		$327 Buy
177
+161
+1,006% +$333 ﹤0.01% 7436
2025
Q1 		$25 Hold
16
– – ﹤0.01% 7337
2024
Q4 		$45 Hold
16
– – ﹤0.01% 7301
2024
Q3 		$62 Buy
+16
New +$90 ﹤0.01% 7285

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Osaic Holdings's SKYE Position: Q1 2026 in Review

Osaic Holdings increased its Skye Bioscience (SKYE) stake by 29,900% in Q1 2026, buying an estimated $487 and bringing the position to 600 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #7489.

Osaic Holdings first reported a position in SKYE in Q3 2024 and has held it in 7 quarters since. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • Osaic Holdings held 600 shares of Skye Bioscience worth $364 as of Q1 2026.
  • Osaic Holdings bought 598 Skye Bioscience shares in Q1 2026, an estimated $487.
  • Skye Bioscience made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7489 holding.
  • Osaic Holdings first reported a position in Skye Bioscience in Q3 2024 and has held it in 7 quarters since.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.